RHY 4.11% 7.0¢ rhythm biosciences limited

Rhy: Proxy forms., page-17

  1. 711 Posts.
    lightbulb Created with Sketch. 661
    Upon rereading, I sense the sarcasm! Wish I had investors so complacent with their money, and bosses as forgiving of extreme levels of failure. Despite having a novel technology, RHY operate in a competitive diagnostics market and commercialisation speed is of the essence. Have a good one.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.